Education

Are you investing in your sleep but wondering if it’s worth it? Join Rocio Fabbro and sleep expert Dr. Michael Breus as they delve into the booming sleep market, the effectiveness of various products, and the surprising habits that may be sabotaging your rest. Discover personalized strategies to improve your sleep quality and learn why…

Minnesota Governor Tim Walz has become a captivating figure within the Democratic Party, showcasing moments of relatability while navigating a challenging political landscape. His tenure has seen a whirlwind of significant legislative achievements, from advancing reproductive rights to ambitious environmental goals. Yet, his journey through crises and controversies reveals a complex portrait of governance. Discover…

Colleen Hoover is taking the literary world by storm, and now she’s stepping into the spotlight with the film adaptation of her hit novel “It Ends With Us,” starring Blake Lively and Justin Baldoni. Discover what makes Hoover’s emotional storytelling resonate deeply with readers and how her unique blend of genres keeps audiences on the…

The tech world mourns the loss of Susan Wojcicki, a visionary leader whose legacy at Google and YouTube transformed online platforms. Her journey, marked by groundbreaking innovations and a commitment to inclusivity, leaves an indelible mark. Discover how Susan’s vibrant spirit and dedication to improving workplaces and education continue to inspire countless individuals. Join the…

Johnson & Johnson takes a bold step in the fight against treatment-resistant depression by seeking FDA approval to use its ketamine-based medication, Spravato, as a standalone treatment. With promising clinical trial results hinting at rapid symptom relief, could this be a game-changer for those who have struggled with traditional antidepressants? Discover the potential impact this…

Discover the inspiring journey of Jake Williams and the UW-Whitewater Wheelchair Basketball Team, a powerhouse with 14 national titles and a legacy of excellence. As they gear up for the Paralympic Games, learn how dedication and community support shape their success. What challenges await them on the road to defending their title? Dive into the…

As the Paralympic Games approach, Sidley Austin associate Matt Simpson is poised for another remarkable journey in goalball. With a history of winning silver medals and overcoming personal challenges, Simpson’s story is one of resilience and dedication. Discover how he balances the demands of a legal career and family life while embracing the thrill of…

Johnson & Johnson is making headlines with a new push for its ketamine-based drug, Spravato, as it seeks FDA approval for standalone use in treating resistant depression. This innovative treatment could change the landscape for millions struggling with major depressive disorder who haven’t found relief from traditional medications. Discover what this could mean for patients…

A new study uncovers a significant shift in GLP-1 drug prescriptions, revealing more patients without diabetes are now seeking these treatments, while those with diabetes are seeing a decline. What does this mean for future access to these essential medications? As demand skyrockets and production struggles to keep pace, the implications could be profound. Dive…

Kristen Faulkner has made history by clinching gold in the Women’s Cycling Road Race, marking a monumental victory for Team USA after four decades. Discover how this once-varsity rower transformed her career and the surprising twists that led her to Olympic glory in Paris. Will she continue her winning streak? Find out more!

Johnson & Johnson is taking a bold step in mental health treatment by seeking FDA approval to expand the use of its ketamine-based medication, Spravato, as a standalone therapy for treatment-resistant depression. With a reported 30% of those with major depressive disorder struggling to find effective treatments, this development could offer hope. Discover how Spravato’s…